These results are consistent with previous data that described anti-proliferative effects of GOFA in colitis-related colon carcinogenesis in vivo, via regulating the activity of the NF-κB-mediated pathway and the expression of proinflammatory cytokines [33]. This evidence concerns the gene NFKB1 and colitis.